These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9810212)

  • 1. [How I evaluate...diabetic nephropathy. First part: micro- and macroalbuminuria].
    Weekers L; Scheen AJ; Lefebvre PJ
    Rev Med Liege; 1998 Aug; 53(8):494-8. PubMed ID: 9810212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.
    McKenna K; Thompson C
    Scott Med J; 1997 Aug; 42(4):99-104. PubMed ID: 9507584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications.
    Chiarelli F; Verrotti A; Mohn A; Morgese G
    Ann Med; 1997 Oct; 29(5):439-45. PubMed ID: 9453292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of microalbuminuria in patients with type 2 diabetes mellitus.
    Jerums G; MacIsaac RJ
    Treat Endocrinol; 2002; 1(3):163-73. PubMed ID: 15799209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
    Viana LV; Gross JL; Camargo JL; Zelmanovitz T; da Costa Rocha EP; Azevedo MJ
    J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of the Micral-Test strip to identify the presence of microalbuminuria in people with insulin dependent diabetes mellitus (IDDM) participating in the EUCLID study.
    Webb DJ; Newman DJ; Chaturvedi N; Fuller JH
    Diabetes Res Clin Pract; 1996 Mar; 31(1-3):93-102. PubMed ID: 8792107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic nephropathy: common questions.
    Thorp ML
    Am Fam Physician; 2005 Jul; 72(1):96-9. PubMed ID: 16035688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is albuminuria screening and treatment optimal in patients with type 2 diabetes in primary care? Observational data of the GIANTT cohort.
    Hellemons ME; Denig P; de Zeeuw D; Voorham J; Lambers Heerspink HJ
    Nephrol Dial Transplant; 2013 Mar; 28(3):706-15. PubMed ID: 23262433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of tests for microalbuminuria screening in patients with diabetes.
    Incerti J; Zelmanovitz T; Camargo JL; Gross JL; de Azevedo MJ
    Nephrol Dial Transplant; 2005 Nov; 20(11):2402-7. PubMed ID: 16105865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme inhibitors in diabetic patients with microalbuminuria or normoalbuminuria.
    Viberti G; Chaturvedi N
    Kidney Int Suppl; 1997 Dec; 63():S32-5. PubMed ID: 9407417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT).
    Kern EF; Erhard P; Sun W; Genuth S; Weiss MF
    Am J Kidney Dis; 2010 May; 55(5):824-34. PubMed ID: 20138413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.
    Barri YM; Palmer BF; Ram CV
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):34-45. PubMed ID: 19667709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is microalbuminuria, an early marker of clinical nephropathy, also a cardiovascular risk factor?].
    Raynaud E; Brun JF; Fédou C; Puech-Cathala AM; Pérez-Martin A; Orsetti A
    Ann Biol Clin (Paris); 1998; 56(6):671-9. PubMed ID: 9853026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for early diabetic nephropathy: which sample to detect microalbuminuria?
    Gatling W; Knight C; Hill RD
    Diabet Med; 1985 Nov; 2(6):451-5. PubMed ID: 2951116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albuminuria and diabetic nephropathy.
    Chang SS
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():974-9. PubMed ID: 18806713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan lowers albuminuria in type 2 diabetic patients treated with angiotensin enzyme inhibitors.
    Mazerska M; Myśliwiec M
    Adv Med Sci; 2009; 54(1):37-40. PubMed ID: 19505872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of diabetic patients for microalbuminuria in primary care--The PROSIT-Project. Proteinuria Screening and Intervention.
    Piehlmeier W; Renner R; Schramm W; Kimmerling T; Garbe S; Proetzsch R; Fahn J; Piwernetz K; Landgraf R
    Exp Clin Endocrinol Diabetes; 1999; 107(4):244-51. PubMed ID: 10433063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.